245 related articles for article (PubMed ID: 15118070)
1. An examination of how different mutations at arginine 855 of the androgen receptor result in different androgen insensitivity phenotypes.
Elhaji YA; Wu JH; Gottlieb B; Beitel LK; Alvarado C; Batist G; Trifiro MA
Mol Endocrinol; 2004 Aug; 18(8):1876-86. PubMed ID: 15118070
[TBL] [Abstract][Full Text] [Related]
2. Impaired helix 12 dynamics due to proline 892 substitutions in the androgen receptor are associated with complete androgen insensitivity.
Elhaji YA; Stoica I; Dennis S; Purisima EO; Lumbroso R; Beitel LK; Trifiro MA
Hum Mol Genet; 2006 Mar; 15(6):921-31. PubMed ID: 16449235
[TBL] [Abstract][Full Text] [Related]
3. The use of androgen receptor amino/carboxyl-terminal interaction assays to investigate androgen receptor gene mutations in subjects with varying degrees of androgen insensitivity.
Ghali SA; Gottlieb B; Lumbroso R; Beitel LK; Elhaji Y; Wu J; Pinsky L; Trifiro MA
J Clin Endocrinol Metab; 2003 May; 88(5):2185-93. PubMed ID: 12727974
[TBL] [Abstract][Full Text] [Related]
4. A novel mutation F826L in the human androgen receptor in partial androgen insensitivity syndrome; increased NH2-/COOH-terminal domain interaction and TIF2 co-activation.
Wong HY; Hoogerbrugge JW; Pang KL; van Leeuwen M; van Royen ME; Molier M; Berrevoets CA; Dooijes D; Dubbink HJ; van de Wijngaart DJ; Wolffenbuttel KP; Trapman J; Kleijer WJ; Drop SL; Grootegoed JA; Brinkmann AO
Mol Cell Endocrinol; 2008 Sep; 292(1-2):69-78. PubMed ID: 18656523
[TBL] [Abstract][Full Text] [Related]
5. Comparison of the molecular consequences of different mutations at residue 754 and 690 of the androgen receptor (AR) and androgen insensitivity syndrome (AIS) phenotype.
Tadokoro R; Bunch T; Schwabe JW; Hughes IA; Murphy JC
Clin Endocrinol (Oxf); 2009 Aug; 71(2):253-60. PubMed ID: 19178528
[TBL] [Abstract][Full Text] [Related]
6. Discordant measures of androgen-binding kinetics in two mutant androgen receptors causing mild or partial androgen insensitivity, respectively.
Shkolny DL; Beitel LK; Ginsberg J; Pekeles G; Arbour L; Pinsky L; Trifiro MA
J Clin Endocrinol Metab; 1999 Feb; 84(2):805-10. PubMed ID: 10022458
[TBL] [Abstract][Full Text] [Related]
7. Bridging structural biology and genetics by computational methods: an investigation into how the R774C mutation in the AR gene can result in complete androgen insensitivity syndrome.
Wu JH; Gottlieb B; Batist G; Sulea T; Purisima EO; Beitel LK; Trifiro M
Hum Mutat; 2003 Dec; 22(6):465-75. PubMed ID: 14635106
[TBL] [Abstract][Full Text] [Related]
8. Partial androgen insensitivity and correlations with the predicted three dimensional structure of the androgen receptor ligand-binding domain.
Yong EL; Tut TG; Ghadessy FJ; Prins G; Ratnam SS
Mol Cell Endocrinol; 1998 Feb; 137(1):41-50. PubMed ID: 9607727
[TBL] [Abstract][Full Text] [Related]
9. In-vitro characterization of androgen receptor mutations associated with complete androgen insensitivity syndrome reveals distinct functional deficits.
Werner R; Zhan J; Gesing J; Struve D; Hiort O
Sex Dev; 2008; 2(2):73-83. PubMed ID: 18577874
[TBL] [Abstract][Full Text] [Related]
10. A novel mutation in the human androgen receptor suggests a regulatory role for the hinge region in amino-terminal and carboxy-terminal interactions.
Deeb A; Jääskeläinen J; Dattani M; Whitaker HC; Costigan C; Hughes IA
J Clin Endocrinol Metab; 2008 Oct; 93(10):3691-6. PubMed ID: 18697867
[TBL] [Abstract][Full Text] [Related]
11. Disrupted amino- and carboxyl-terminal interactions of the androgen receptor are linked to androgen insensitivity.
Thompson J; Saatcioglu F; Jänne OA; Palvimo JJ
Mol Endocrinol; 2001 Jun; 15(6):923-35. PubMed ID: 11376111
[TBL] [Abstract][Full Text] [Related]
12. Human androgen insensitivity due to point mutations encoding amino acid substitutions in the androgen receptor steroid-binding domain.
Murono K; Mendonca BB; Arnhold IJ; Rigon AC; Migeon CJ; Brown TR
Hum Mutat; 1995; 6(2):152-62. PubMed ID: 7581399
[TBL] [Abstract][Full Text] [Related]
13. Functional analysis of a novel androgen receptor mutation, Q902K, in an individual with partial androgen insensitivity.
Umar A; Berrevoets CA; Van NM; van Leeuwen M; Verbiest M; Kleijer WJ; Dooijes D; Grootegoed JA; Drop SL; Brinkmann AO
J Clin Endocrinol Metab; 2005 Jan; 90(1):507-15. PubMed ID: 15486055
[TBL] [Abstract][Full Text] [Related]
14. Human androgen receptor gene ligand-binding-domain mutations leading to disrupted interaction between the N- and C-terminal domains.
Jääskeläinen J; Deeb A; Schwabe JW; Mongan NP; Martin H; Hughes IA
J Mol Endocrinol; 2006 Apr; 36(2):361-8. PubMed ID: 16595706
[TBL] [Abstract][Full Text] [Related]
15. Partial androgen insensitivity with phenotypic variation caused by androgen receptor mutations that disrupt activation function 2 and the NH(2)- and carboxyl-terminal interaction.
Quigley CA; Tan JA; He B; Zhou ZX; Mebarki F; Morel Y; Forest MG; Chatelain P; Ritzén EM; French FS; Wilson EM
Mech Ageing Dev; 2004; 125(10-11):683-95. PubMed ID: 15541764
[TBL] [Abstract][Full Text] [Related]
16. Impaired nuclear translocation, nuclear matrix targeting, and intranuclear mobility of mutant androgen receptors carrying amino acid substitutions in the deoxyribonucleic acid-binding domain derived from androgen insensitivity syndrome patients.
Kawate H; Wu Y; Ohnaka K; Tao RH; Nakamura K; Okabe T; Yanase T; Nawata H; Takayanagi R
J Clin Endocrinol Metab; 2005 Nov; 90(11):6162-9. PubMed ID: 16118342
[TBL] [Abstract][Full Text] [Related]
17. Partial androgen insensitivity caused by an androgen receptor mutation at amino acid 907 (Gly-->Arg) that results in decreased ligand binding affinity and reduced androgen receptor messenger ribonucleic acid levels.
Choong CS; Sturm MJ; Strophair JA; McCulloch RK; Tilley WD; Leedman PJ; Hurley DM
J Clin Endocrinol Metab; 1996 Jan; 81(1):236-43. PubMed ID: 8550758
[TBL] [Abstract][Full Text] [Related]
18. Mutations in the amino-terminal domain of the human androgen receptor may be associated with partial androgen insensitivity and impaired transactivation in vitro.
Holterhus PM; Werner R; Struve D; Hauffa BP; Schroeder C; Hiort O
Exp Clin Endocrinol Diabetes; 2005 Sep; 113(8):457-63. PubMed ID: 16151980
[TBL] [Abstract][Full Text] [Related]
19. Five novel androgen receptor gene mutations associated with complete androgen insensitivity syndrome.
Jääskeläinen J; Mongan NP; Harland S; Hughes IA
Hum Mutat; 2006 Mar; 27(3):291. PubMed ID: 16470553
[TBL] [Abstract][Full Text] [Related]
20. Phenotypic features, androgen receptor binding, and mutational analysis in 278 clinical cases reported as androgen insensitivity syndrome.
Ahmed SF; Cheng A; Dovey L; Hawkins JR; Martin H; Rowland J; Shimura N; Tait AD; Hughes IA
J Clin Endocrinol Metab; 2000 Feb; 85(2):658-65. PubMed ID: 10690872
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
